Imiglucerase

Cerezyme

400 UNIT / VIAL Powder For SolutionCanadaMarketedAuthorised 14 Jun 2000

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Imiglucerase

Cerezyme

400 UNIT / VIAL Powder For SolutionCanadaMarketedAuthorised 14 Jun 2000

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Cerezyme 400 E, poeder voor oplossing voor infusieNetherlands · Genzyme Europe BV

Cerezyme 400URomania · 400U · pulb. pt.conc. pt.sol. perf. · Genzyme Europe BV

Cerezyme®Serbia · 400j. · prašak za koncentrat za rastvor za infuziju · Amicus SRB D.O.O.

CEREZYME 400 U powder for concentrate for solution for infusionSaudi Arabia · Genzyme Ireland Limited

Cerezyme® (Imiglucerase) 400U Powder for solution for injectionSingapore · 424 U · injection, powder, for solution · Sanofi-Aventis Singapore Pte. LTD.

CerezymeUnited States · 200 UNITS/VIAL, 400 UNITS/VIAL · injectable · Genzyme

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Imiglucerase
Strength: 400 UNIT / VIAL
Dosage form: Powder For Solution
Route: Intravenous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 14 Jun 2000
Registration: DIN 02241751
Marketing authorisation holder: Sanofi-Aventis Canada INC
ATC code: A16AB02
Group: Alimentary tract and metabolism
Supply: PRESCRIPTION, SCHEDULE D